Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A.

Jia-Yong Wu,Feng-nan Niu,Rong Huang,Yun Xu
DOI: https://doi.org/10.1097/WNR.0b013e328308b355
2008-01-01
Neuroreport
Abstract:Histone deacetylases (HDAC) inhibitors have been emerging as neuroprotective agents by acting on neurons and microglia. In this study, we found trichostatin A (TSA), a HDAC inhibitor, could inhibit the elevation of glutamate in 150 mu M 1-methyl-4-phenylpyridinium (MPP(+))-treated primary cultured astrocytes medium when its concentration reached 132 nM. TSA of 132 nM or more could promote the uptake of [(3)H]-D, L-glutamate by astrocytes. Further study showed the downregulation of glutamate transporter I and glutamate/aspartate transporter induced by MPP+ were prevented by TSA. Therefore, these findings suggested TSA could alleviate MPP(+)-induced impairment of astrocytic glutamate uptake, which might be a novel mechanism contributing to neuroprotection by HDAC inhibitors.
What problem does this paper attempt to address?